Recommended vaccination schedule for adults, United States, 2022*
Appendix A: Members of ACIP and the ACIP Combined Immunization Task Force
Recommendations for the routine use of vaccines in children, adolescents and adults are developed by the Advisory Committee on Immunization Practices (ACIP). ACIP is accredited as a Federal Advisory Committee to provide expert external advice and guidance to the Director of the Centers for Disease Control and Prevention (CDC) on the use of vaccines and related agents to control preventable diseases by vaccination in the civilian population of the United States. states. Recommendations for the routine use of vaccines in children and adolescents are harmonized to the extent possible with the recommendations of the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP) and the ‘American College of Obstetricians and Gynecologists (ACOG). Recommendations for routine use of vaccines in adults are harmonized with recommendations from the AAFP, ACOG, American College of Physicians (ACP), American College of Nurse-Midwives (ACNM) and the American Academy of Physician Assistants (AAPA). ACIP recommendations adopted by the CDC Director become agency guidelines on the date of publication in the Morbidity and Mortality Weekly Report (MMWR). Additional information about ACIP is available at www.cdc.gov/vaccines/acip.
Members of ACIP
Unless otherwise noted, members listed were non-author contributors to this article.
Jose R. Romero, MD, University of Arkansas for Medical Sciences, Children’s Hospital of Arkansas, Little Rock, Arkansas (Chair); Amanda Cohn, MD, Centers for Disease Control and Prevention, Atlanta, Georgia (Executive Secretary); Robert L. Atmar, MD, Baylor College of Medicine, Houston, TX; Kevin A. Ault, MD*, University of Kansas Medical Center, Kansas City, Kansas; Lynn Bahta, RN, MPH, CPH, Minnesota Department of Health, Saint Paul, Minnesota; Beth P. Bell, MD, MPH, University of Washington, Seattle, Washington; Henry Bernstein, DO, MHCM*, Cohen Children’s Medical Center, New Hyde Park and Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Sybil Cineas, MD, Brown University Warren Alpert School of Medicine, Providence, Rhode Island; Sharon E. Frey, MD, Saint Louis University School of Medicine, Saint Louis, Missouri; Paul Hunter, MD, City of Milwaukee Department of Health, Milwaukee, Wisconsin; Grace M. Lee, MD, MPH, Lucile Packard Children’s Hospital, Stanford University School of Medicine, Stanford, Calif.; Veronica V. McNally, JD, Franny Strong Foundation, West Bloomfield, Michigan; Katherine A. Poehling, MD, MPH, Wake Forest School of Medicine, Winston-Salem, NC; Pablo J. Sánchez, MD, Nationwide Children’s Hospital Research Institute, Columbus, Ohio; Peter Szilagyi, MD, MPH, University of California, Los Angeles, Los Angeles, CA; Helen Keipp Talbot, MD, MPH, Vanderbilt University, Nashville, Tennessee. A list of current ACIP members is available at www.cdc.gov/vaccines/acip/committee/members.html.
ACIP Combined Immunization Working Group
Co-chair of the working group: Kevin A. Ault, MD*, Kansas City, Kansas.
Members of the working group: Sybil Cineas, MD, Providence, Rhode Island; Sarah Coles, MD, Phoenix, Ariz.; Katherine Debiec, MD, Seattle, Washington; Marci Drees, MD, Philadelphia, Pennsylvania; John Epling, MD, Roanoke, Virginia; Holly Fontenot, PhD, Boston, MA; Sandra Fryhofer, MD, Atlanta, Georgia; Molly Howell, MPH, Bismarck, ND; Marie-Michelle Leger, MPH, PA-C, Alexandria, Virginia; Susan Lett, MD, MPH, Boston, MA; Veronica V. McNally, JD, West Bloomfield, Michigan; Sarah McQueen, DMS, PA-C, Charlotte, NC; Amy Middleman, MD, MSEd, MPH, Oklahoma City, Oklahoma; Sean O’Leary, MD, MPH, Denver, Colorado; Chad Rittle, DNP, MPH, RN, Pittsburgh, PA; William Schaffner, MD, Nashville, TN; Ken Schmader, MD, Durham, NC; Rhoda Sperling, MD, New York, New York; Patricia Stinchfield, RN, MS, St. Paul, Minnesota; Thomas Weiser, MD, MPH, Portland, Oregon.
Contributors to the working group: Anna M. Acosta, MD, Atlanta, Georgia; Tara C. Anderson, DMV, PhD, Atlanta, Georgia; Kathy Byrd, MD, MPH, Atlanta, Georgia; Margaret M. Cortese, MD, Atlanta, Georgia; Kathleen Dooling, MD, MPH, Atlanta, Georgia; Amy Parker Fiebelkorn, MSN, MPH, Atlanta, Georgia; Mark Freedman, DMV, MPH, New York, New York; Paul A. Gastañaduy, MD, Atlanta, Georgia; Lisa Grohskopf, MD, MPH, Atlanta, Georgia; Susan Hariri, PhD, Atlanta, Georgia; Aaron M. Harris, MD, Atlanta, Georgia; Fiona Havers, MD, PhD, Atlanta, Georgia; Holly Hill, PhD, MD, Atlanta, Georgia; Tara Jatlaoui, MD, MPH, Atlanta, Georgia; Suzanne Johnson-DeLeon, MPH, Atlanta, Georgia; Miwako Kobayashi, MD, MPH, Atlanta, Georgia; Ram Kopakka, MD, MPH, Atlanta, Georgia; Andrew Kroger, MD, MPH, Atlanta, Georgia; Tatiana M. Lanzieri, MD, Atlanta, Georgia; Lucy McNamara, PhD, MS, Atlanta, Georgia; Mona Marin, MD, Atlanta, Georgia; Lauri Markowitz, MD, Atlanta, Georgia; Sarah A. Mbaeyi, MD, Atlanta, Georgia; Elissa Meites, MD, MPH, Atlanta, Georgia; Noele P. Nelson, MD, PhD, Atlanta, Georgia; Sara Oliver, MD, MSPH, Atlanta, Georgia; Priti Patel, MD, MPH, Atlanta, Georgia; Tamara Pilishvili, MPH, BS, Atlanta, Georgia; Hilda Razzaghi, PhD, Atlanta, Georgia; Janell Routh, MD, Atlanta, Georgia; Sarah Schillie, MD, Atlanta, Georgia; Mark K. Weng, MD, Atlanta, Georgia; Akiko Wilson, BFA, Atlanta, Georgia; JoEllen Wolicki, BSN, Atlanta, Georgia.
Working Group Advisors: Henry Bernstein, DO, MHCM*, New Hyde Park, New York; Caroline Bridges, MD, Moscow, Idaho; Kathleen Harriman, PhD, MPH, RN, Richmond, CA; Robert H. Hopkins Jr., MD, Little Rock, Arkansas; Karen Ketner, DNP, Redwood City, CA; David Kim, MD, MPH, Washington, DC; Jane Kim, MD, MPH, Durham, NC; Diane Peterson, St. Paul, Minnesota; Litjen Tan, PhD, Chicago, Illinois.
Co-leaders of the working group: Neil Murthy, MD, MPH, MSJ*, Atlanta, Georgia; A. Patricia Wodi, MD, MPH*.
* Author of the article.